RAD 2.78% 3.7¢ radiopharm theranostics limited

It is the short-cut for sure. FDA dont usually suggest a Ph2b/3...

  1. 61 Posts.
    lightbulb Created with Sketch. 7
    It is the short-cut for sure.
    FDA dont usually suggest a Ph2b/3 right after Ph1b/2a, given the sample size of RAD101 trial history.
    Sometimes they still require a complete Ph2 to test on patient in different doses.
    Last edited by ttseng13: 29/05/23
 
watchlist Created with Sketch. Add RAD (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
0.001(2.78%)
Mkt cap ! $39.12M
Open High Low Value Volume
3.6¢ 3.7¢ 3.6¢ $23.68K 650.5K

Buyers (Bids)

No. Vol. Price($)
1 125225 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 300000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
RAD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.